2nd Quarter - Report

GENOMIC HEALTH for GENOMIC HEALTH

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reimbursement of Lab Tests, Regulation of Lab Tests, Coverage of Lab Tests

LobbyistCovered position, as disclosed
ANDREA BERGMAN 1999-2001, Asst S. Michael Crapo
PAUL RADENSKY —
DANIELLE SCELFO —
SHEILA WALCOFF 2006-2006, HHS Counsel to Secretary Leavitt, 2004-2006 FDA
ERIC ZIMMERMAN —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.